COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial

Study acronym: CONTRAST
StatusCompleted
PhaseNot specified
SponsorFred Apple
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Hennepin Healthcare Research Institute to Fred Apple Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 2286 participants (planned 2000)
    • Study completion date changed from estimate of Dec 31, 2025 to Feb 13, 2026
    • Eligibility criteria expanded, about 9 words
  2. Study completion date: Dec 31, 2023 to Dec 31, 2025v12
  3. Re-verified, no change to tracked fieldsv11
  4. Primary completion date: Dec 31, 2021 to Dec 31, 2022
    • Study completion date: Dec 31, 2021 to Dec 31, 2023
    v10
  5. Primary completion date: Dec 31, 2020 to Dec 31, 2021v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary completion date: Dec 31, 2019 to Dec 31, 2020
    • Study completion date: Dec 31, 2019 to Dec 31, 2021
    v8
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Sep 2018 to Dec 31, 2019
    • Study completion date: Dec 2018 to Dec 31, 2019
    v6
  4. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Apr 2018 to Sep 2018
    • Site details revised
    v5
  5. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Dec 2017 to Apr 2018
    • Study completion date: Dec 2017 to Dec 2018
    • Start date changed from estimate of Oct 2017 to Nov 6, 2017
  6. Start date: Aug 2017 to Oct 2017v3
  7. Primary endpoints: 2 to 1
    • Secondary endpoints: 5 to 6
    • Study description expanded, about 96 words
    • Eligibility criteria expanded, about 2 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
Trial Details
NCT Number NCT03214029
Lead Sponsor Fred Apple
Collaborators: Abbott Diagnostics Division, Hennepin County Medical Center, Minneapolis
Conditions
(from sponsor)		 Acute Myocardial Infarction, Acute Coronary Syndrome
Related terms Acute Coronary Syndrome
Enrollment 2,286 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov